Clear association between serum levels of adipokines and T-helper 17-related cytokines in patients with psoriasis

Clinical and Experimental Dermatology

Volumn 38, Issue 1, 2013, Pages 66-70

  Nakajima, Hideki ^a   Nakajima, K ^a   Tarutani, M ^a   Sano, S ^a  

^a KOCHI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; CHEMERIN; CYTOKINE; INTERLEUKIN 22; INTERLEUKIN 6; LEPTIN; RESISTIN; RETINOID BINDING PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; PATHOGENESIS; PRIORITY JOURNAL; PSORIASIS; TH17 CELL;

ADIPOKINES; ADULT; AGED; AGED, 80 AND OVER; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; PSORIASIS; REGRESSION ANALYSIS; SEVERITY OF ILLNESS INDEX; TH17 CELLS;

EID: 84872833230     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2012.04465.x     Document Type: Article

References (25)

1. Love TJ, Qureshi AA, Karlson EW, et al. Prevalence of the metabolic syndrome in psoriasis. Arch Dermatol 2011; 147: 419-24.
2. Takahashi H, Iizuka H,. Psoriasis and metabolic syndrome. J Dermatol 2011; 38: 1-7.
3. Nakajima H, Nakajima K, Tarutani M, et al. Kinetics of circulating Th17 cytokines and adipokines in psoriasis patients. Arch Dermatol Res 2011; 303: 451-5.
4. Lowes MA, Kikuchi T, Fuentes-Duculan J, et al. Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J Invest Dermatol 2008; 128: 1207-11.
5. Korn T, Bettelli E, Gao W, et al. IL-21 initiates an alternative pathway to induce proinflammatory T (H) 17 cells. Nature 2007; 448: 484-7.
6. Nakajima H, Nakajima K, Nagano Y, et al. Circulating chemerin is upregulated in psoriasis. J Dermatol Sci 2010; 60: 45-7.
7. Cash JL, Hart R, Russ A, et al. Synthetic chemerin derived peptide suppress inflammation through ChemR23. J Exp Med 2008; 205: 767-75.
8. Yoshimura T, Oppenheim JJ,. Chemerin reveals its chimeric nature. J Exp Med 2008; 205: 2187-90.
9. Silswal N, Singh AK, Arana B, et al. Human resistin stimulates the proinflammatory cytokines TNF-α and IL-12 in macrophages by NF-kappaB-dependent pathway. Biochem Biophys Res Commun 2005; 334: 1092-101.
10. Kaser S, Kaser A, Sandhofer A, et al. Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro. Biochem Biophys Res Commun 2003; 309: 286-90.
11. Kitatani N, Taniguchi A, Fukushima M, et al. Association of serum resistin with TNF system activity in Japanese type 2 diabetic patients. Diabetes Metab 2007; 33: 156-7.
12. Vitkova M, Klimcakova E, Kovacikova M, et al. Plasma levels and adipose tissue messenger ribonucleic acid expression of retinol-binding protein 4 are reduced during calorie restriction in obese subjects but are not related to diet-induced changes in insulin sensitivity. J Clin Endocrinol Metab 2007; 92: 2330-5.
13. Yao-Borengasser A, Varma V, Bodles AM, et al. Retinol binding protein 4 expression in humans: relationship to insulin resistance, inflammation, and response to pioglitazone. J Clin Endocrinol Metab 2007; 92: 2590-7.
14. Sell H, Eckel J,. Regulation of retinol binding protein 4 production in primary human adipocytes by adiponectin, troglitazone and TNF-alpha. Diabetologia 2007; 50: 2221-3.
15. Broch M, Ramírez R, Auguet MT, et al. Macrophages are novel sites of expression and regulation of retinol binding protein-4 (RBP-4). Physiol Res 2010; 59: 299-303.
16. Shea J, Randell E, Vasdev S, et al. Serum retinol-binding protein 4 concentrations in response to short-term overfeeding in normal-weight, overweight, and obese men. Am J Clin Nutr 2007; 86: 1310-15.
17. Brochu-Gaudrea K, Rehfeldt C, Blouin R, et al. Adiponectin action from head to toe. Endocrine 2010; 37: 11-32.
18. Seino Y, Hirose H, Saito I, et al. High molecular weight multimer form of adiponectin as a useful marker to evaluate insulin resistance and metabolic syndrome in Japanese men. Metabolism 2007; 56: 1493-9.
19. Almeda-Valdes P, Cuevas-Ramos D, Mehta R, et al. Total and high molecular weight adiponectin have similar utility for the identification of insulin resistance. Cardiovasc Diabetol 2010; 9: 26.
20. Wolf AM, Wolf D, Rumpold H, et al. Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes. Biochem Biophys Res Commun 2004; 323: 630-5.
21. Abke S, Neumeier M, Weigert J, et al. Adiponectin-induced secretion of interleukin-6 (IL-6), monocyte chemotactic protein-1 (MCP-1, CCL-2) and interleukin-8 (IL-8, CXCL-8) is impaired in monocytes from patients with type I diabetes. Cardiovasc Diabetol 2006; 5: 17.
22. Lee JM, Kim SR, Yoo SJ, et al. The relationship between adipokines, metabolic parameters and insulin resistance in patients with metabolic syndrome and type 2 diabetes. J Int Med Res 2009; 37: 1803-12.
23. Feuerer M, Herrero L, Cipolletta D, et al. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med 2009; 15: 930-9.
24. Kollias A, Tsiotra PC, Iknonomidis I, et al. Adiponectin levels and expression of adiponectin receptors in isolated monocytes from overweight patients with coronary artery disease. Cardiovasc Diabetol 2011; 10: 14.
25. Takahashi H, Tsuji IH, Takahashi Y, et al. Plasma adiponectin and leptin levels in Japanese patients with psoriasis. Br J Dermatol 2008; 159: 1207-8.